✦ LIBER ✦

P-481 Cisplatin+gemcytabine versus cisplatin+vinorelbine in patients with stage IV nonsmall cell lung cancer (NSCLC): Results of single center experience

✍ Scribed by Er, O.; Ozkan, M.; Coskun, S.; Dogu, G.; Altinbas, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-461 Modified weekly schedule of cispla

✍ Boussem, H.; Benna, F.; Bourguiba, M.; Hamzaoui, A.; Kilani, T.; Lagha, M.; Megd 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Multicenter randomized phase II trial as

✍ Pérol, M; Lena, H; Thomas, P; Robinet, G; Fournel, P; Coste, E; Belleguic, C; Le 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

14 Phase II study of biweekly vinorelbin

✍ Chen, Chih-Hung; Chang, Wen-Jeng; Tsai, Ying-Hwang; Tsao, Thomas C.Y. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Randomized, double-blind phase II study

✍ Reinmuth, N.; Meyer, A.; Hartwigsen, D.; Schaeper, C.; Huebner, G.; Skock-Lober, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 682 KB

P-562 Evaluation of bexarotene (Targreti

✍ Ramlau, R.; Zatloukal, P.; Tadokoro, H.; Jassem, J.; Hao, D.; Orlov, S.; Gottfri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB